DNA extraction is the technique used to isolate DNA in a biological sample. It is a method used to purify DNA by using physical/chemical methods from a sample separating DNA from cell membranes, proteins, and/or other cellular components. Once extracted, DNA can be used for molecular analyses including PCR, electrophoresis, sequencing, fingerprinting and cloning. The DNA testing process is comprised of four main steps, including extraction, quantitation, amplification, and capillary electrophoresis. The primary use of these extractions is for DNA profiling of various organisms to better understand and/or to identify the unknown organism.
The global DNA extraction kits market is estimated to account for US$ 1,489.7 Mn in terms of value by the end of 2021.
The outbreak of COVID-19 across the world is expected to boost the growth of the global DNA extraction kits market over the forecast period. For instance, the high infection rate of COVID-19 has led to the development and launch of many DNA and RNA based COVID-19 kits. For instance, in April 2020, PHASE Scientific launched the PHASIFY VIRAL RNA extraction kit for the detection of the COVID-19 virus, worldwide. Furthermore, pharmaceutical companies and researchers across the world are focusing on developing specific assays and kits for rapid detection of SARS-CoV-2 (COVID-19).
Increase in prevalence of cancer across the globe is expected to offer significant opportunities for players in the global DNA extraction kits market. For instance, a patient suffering from any kind of cancer, circulating cell-free DNA, which originates from cancer cells, is found in the bloodstream, known as circulating tumor DNA (ctDNA). For instance, in May 2018, BioChain Institute Inc. announced the launch of new cell-free DNA extraction kit, cfPure, for the efficient isolation and detection of circulating cell-free DNA (ccfDNA). Thus, with the rise in incidence of cancer, the use of DNA extraction kit is also expected to increase.
Lack of awareness about DNA extraction kits and high cost of kits are major factors expected to hamper the growth of the global DNA extraction kits market. For instance, technologically advanced DNA extraction kits are expensive as compared to conventional methods. Moreover, DNA extraction for samples of different sizes using different kits can be expensive. New DNA extraction kits are also expensive than the conventional models are available in the market.
Global DNA Extraction Kits Market - Impact of Coronavirus (Covid-19) Pandemic
Due to the rapid spread of the coronavirus, the demand for diagnostic kits and other critical care medical devices has witnessed exponential growth in the last two years. The high infection rate of COVID-19 and research activities by key companies in the area of sequencing to expand their knowledge about the virus and its origin, along with the molecular diagnostics of the SARS-CoV-2 virus, led to the development and launch of many DNA/RNA based COVID-19 kits. For instance, in September 2021, Thermo Fisher Scientific planned to manufacture nucleic acid isolation kits India. Thermo Fisher Scientific’s manufacturing unit is now being used to manufacture CoviPath RT-PCR Covid-19 test kits for Indian customers.
The global DNA extraction kits market was valued at US$ 1,389.7 Mn in 2021 and is forecast to reach a value of US$ 2,320.6 Mn by 2028 at a CAGR of 7.7% between 2022 and 2028.
Among product, cell-free DNA segment held dominant position in the global DNA extraction kits market in 2020, accounting for 46.5% share in terms of value, increasing approval and launch of new products is expected to propel growth of the segment during the forecast period.
Major players operating in the global DNA extraction kits market include Thermo Fisher Scientific, QIAGEN, PROMEGA, F. Hoffmann-La Roche, Bio-Rad Laboratories, and Agilent Technologies, among others.
In January 2020, QIAGEN stated that it has completed 2,500 placements of its QIAsymphony instrument. These placements represent a great milestone for QIAGEN’s magnetic bead-based instruments. QIAsymphony has the broadest test portfolio of any platform in its category in the European market.
In April 2020, Thermo Fisher Scientific, Inc. collaborated with Hamilton Company to develop an automated nucleic acid extraction platform for forensic laboratory purposes. The ID NIMBUS Presto assay facilitates automated DNA extraction from samples collected from the crime scene.